Article: Fort Worth, Texas-Based Alcon Posts 58 Percent Rise in Fourth-Quarter Earnings.

By Maria M. Perotin, Fort Worth Star-Telegram, Texas Knight Ridder/Tribune Business News

Feb. 12--Brisk sales pushed Alcon's fourth-quarter earnings to $133.9 million, up almost 58 percent from a year earlier.

That amounted to 43 cents per share for the Fort Worth-based maker of eye-care products, which released its financial results after the stock market closed Wednesday. Sales climbed 13.7 percent to $851.7 million.

Much of the fourth-quarter growth came from sales of drugs, including Ciprodex Otic, which treats ear infections, and Travatan, a glaucoma treatment.

Alcon's U.S. sales rose 7.8 percent, while international sales ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!